Beyond their primary application in the management of type 2 diabetes mellitus (T2DM), GLP-1RAs have demonstrated significant therapeutic potential in treating obesity
Heres whats really happening: Its about rapid weight loss, not the drug itself
The need for treating obesity as a chronic condition is highlighted by the fact that weight regain happens after stopping semaglutide, despite lifestyle modifications [116]
In a more rational market not driven by legally-exempted rebate kickbacks paid to vertically integrated (with commercial health insurance companies) PBMs
The all-inclusive pricing eliminates the surprise fees that plague some telehealth competitors, where you might see a low medication price only to discover separate charges for consultations, shipping, supplies, and follow-ups
Behavior Change and Implementation Supports Group-Based Visits Group medical visits (GMVs) or shared medical appointments are an increasingly established, evidence-based modality to provide effective lifestyle therapy in a comprehensive, easy-to-access medium
